Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Oncoimmunology|July 9, 2015
Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosisMarieta Toma, Rebekka Wehner, Anja Kloß, et al.
Urology|May 12, 2004
Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer programPeter Iversen, Manfred P Wirth, William A See, et al.
World Journal of Urology|June 15, 2016
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011Matthias May, Hans-Martin Fritsche, Malte W Vetterlein, et al.
Cancer Research|March 18, 2016
An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer CellsClaudia Peitzsch, Monica Cojoc, Linda Hein, et al.
The Journal of Urology|July 20, 2002
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer programWilliam A See, Manfred P Wirth, David G McLeod, et al.
BJU International|July 30, 2013
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project)Sabine D Brookman-May, Matthias May, Shahrokh F Shariat, et al.
Clinical Genitourinary Cancer|July 4, 2013
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysisSabine Brookman-May, Matthias May, Shahrokh F Shariat, et al.
BJU International|March 9, 2013
Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US studyLuca Cindolo, Paolo Chiodini, Sabine Brookman-May, et al.
European Urology Focus|July 30, 2017
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks AnalysisMalte W Vetterlein, Thomas Seisen, Matthias May, et al.
BJU International|November 11, 2014
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-makingAtiqullah Aziz, Shahrokh F Shariat, Florian Roghmann, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Oncoimmunology|July 9, 2015
Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosisMarieta Toma, Rebekka Wehner, Anja Kloß, et al.
Urology|May 12, 2004
Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer programPeter Iversen, Manfred P Wirth, William A See, et al.
World Journal of Urology|June 15, 2016
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011Matthias May, Hans-Martin Fritsche, Malte W Vetterlein, et al.
Cancer Research|March 18, 2016
An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer CellsClaudia Peitzsch, Monica Cojoc, Linda Hein, et al.
The Journal of Urology|July 20, 2002
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer programWilliam A See, Manfred P Wirth, David G McLeod, et al.
BJU International|July 30, 2013
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project)Sabine D Brookman-May, Matthias May, Shahrokh F Shariat, et al.
Clinical Genitourinary Cancer|July 4, 2013
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysisSabine Brookman-May, Matthias May, Shahrokh F Shariat, et al.
BJU International|March 9, 2013
Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US studyLuca Cindolo, Paolo Chiodini, Sabine Brookman-May, et al.
European Urology Focus|July 30, 2017
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks AnalysisMalte W Vetterlein, Thomas Seisen, Matthias May, et al.
BJU International|November 11, 2014
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-makingAtiqullah Aziz, Shahrokh F Shariat, Florian Roghmann, et al.
Pageof 28